Atlas Trials

Low Dose Atropine for Symptomatic Vitreous Floaters

Clinical trial NCT06174935 · UNKNOWN

Trial details

NCT number
NCT06174935
Sponsor
Jeanette Du
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Vitreous Floaters
Start date
2024-01-01
Primary completion
2024-06-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.